Mitzi Nagarkatti to Killer Cells, Lymphokine-Activated
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Killer Cells, Lymphokine-Activated.
Connection Strength
0.417
-
Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. J Biol Chem. 2003 Oct 31; 278(44):43818-30.
Score: 0.221
-
Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma. PLoS One. 2012; 7(4):e35650.
Score: 0.101
-
Blockade of hyaluronan inhibits IL-2-induced vascular leak syndrome and maintains effectiveness of IL-2 treatment for metastatic melanoma. J Immunol. 2007 Sep 15; 179(6):3715-23.
Score: 0.074
-
Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J Immunol. 1999 Aug 01; 163(3):1619-27.
Score: 0.010
-
Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J Immunol. 1998 Sep 15; 161(6):3077-86.
Score: 0.010